To confirm this hypothesis, we silenced SPRY2 after knocking out SLNCR1 in melanoma cells, and found that the silencing of SPRY2 reversed SLNCR1 mediated proliferation, migration, and angiogenesis as well as tumor growth. The gene discussed is SPRY2; the disease is melanoma.